Advertisement
Screener

GeneDx Holdings Corp. (WGS) Income (Loss) from Continuing Operations before Income Taxes, Domestic

GeneDx Holdings Corp. Income (Loss) from Continuing Operations before Income Taxes, Domestic

GeneDx Holdings Corp. (WGS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$22.32 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-23

  • GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$22.32M.
  • GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$53.56M.
  • GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$177.32M.
  • GeneDx Holdings Corp. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$598.14M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31-$22.32M
10-K · filed 2026-02-23
2024-12-31-$53.56M
10-K · filed 2026-02-23
2023-12-31-$177.32M
10-K · filed 2026-02-23
2022-12-31-$598.14M
10-K · filed 2024-02-23
2021-12-31-$245.39M
10-K · filed 2023-03-16
2020-12-31-$241.34M
10-K · filed 2023-03-16
2019-12-31-$29.70M
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B